Global Strategy Lead, Rare Bone and Endocrine Disorders

• Bachelor's degree in business or life sciences; a Masters degree would be supportive
• Minimum 10+ years in pharmaceutical or biotech industry in roles encompassing strategic pre-launch planning and launch, with global/regional/local experience and thorough understanding of the diverse requirements of Global markets
• Country and/ or above-country leadership experience in the pharmaceutical or biotechnology industry with accountability and a proven track record for delivering on business goals in a major healthcare market; PnL responsibility would be supportive
• Broad marketing and commercial experience with demonstrated success across various stages of the brand lifecycle, including pre-launch planning, launch execution, and long-term business planning
• Profound understanding of drug development and commercialization in rare disease
• Solid grasp of ongoing paradigm changes and future trends in healthcare commercialization
• Demonstrated ability to collaborate across matrix teams and achieve goals by delivering through others
• Proven experience and knowledge of a broad base of external partners and customers including patients, prescribers, payors, providers and in/out license partners.
• P&L management experience and ability to build a financial Business Case
• Experienced with key global regulations in the field of pharmaceutical compliance and commercialization, including pharmacovigilance
• Excellent communications skills across a diverse set of stakeholders (commercial, clinical, medical, etc.)

• An advanced degree (MBA, MSc or PhD) is preferred
• Pharmaceutical or Biotech experience at the Global, Regional and Local level.
• You bring an entrepreneurial spirit and strategic mindset including innovation and critical thinking with performance-oriented drive.
• You can integrate a variety of perspectives into meaningful strategies and programs.
• You embrace curiosity, collaboration and smart risk taking as a prerequisite for joint success.
• You enthusiastically embrace the diversity of individual healthcare ecosystems as significant opportunity.
• You can relate and connect deeply with various healthcare and business markets to deliver direction and support.
• You can create and mobilize an inclusive work environment of highest integrity and quality, fostering learning, growth, teamwork, individual development and attraction of top talent.
• You possess excellent communication skills and a strong personal presence internally and externally, acting as a strong catalyst and influencer.

Alexion's Global Marketing and Market Access team (GMMA) is an integrated strategy and operations team, with the core objective to develop disease and brand commercial and access strategies, as well as global marketing materials and negotiation strategies, while working closely with markets for implementation. The team diligently monitors the performance of the business and the effectiveness of our strategies, helping to position our brands for sustained long-term access and success. Additionally, the GMMA team delivers commercial strategies for our pipeline programs and establishes commercial marketing and access strategies for new product launches. Our unique culture thrives on collaboration, authenticity, creativity, and pushing boundaries in all that we do to advance patient care.

The Global Brand Strategy Lead, Rare Bone and Endocrine Disorders is a foundational role for the success of the Hypophosphatasia (HPP) company strategy with focus on our Top 21 countries. You are accountable for leading the development and profitable management of our Hypophosphatasia portfolio with full accountability for commercialization. You have a leadership role within a matrix working model between global and local markets and across functions. Working in complex and competitive markets, you are accountable for creating a collaborative and high-performance environment that supports the innovation required to identify and realize substantial value opportunities.

• You are responsible for the VST (Lead of Value Sub team) in which you will refine, and safeguard strategic value propositions based on market events and clinical outcomes. In collaboration with Medical and Market Access teams to develop proposals and business cases for further data generation and RWE
• You lead the DSP (Disease Strategy Plan) development and roll-out. Provide input into strategic planning process (patient funnel, patient journey, patient segmentation, et al). Prioritize the critical success factors and associated tactics coming out of the DSP and lead project workstreams for pull-through. Additionally, you will lead planning meetings with key stakeholders to align on DSP development and enterprise approval.
• You are accountable for ensuring CI and Market Research plans are aligned to commercial strategy for your portfolio and ensure the enterprise is prepared for competitive assets in the marketplace
• You are part of the GPT Core Team member (Global Program Team), keeping the GPT apprised of key programs and workstreams. As well as collaborate and align with key functions and government bodies i.e. Regional Area Heads (US, INTL, JP), GPT, GST, Clinical, Development, Regulatory, SciComms, Training etc.
• You provide regular updates on strategy and global performance to senior leadership, e.g. GCOLT (Global Commercial Leadership Team)
• You are accountable for driving the Global Pre-Launch strategy and planning 12-18 months prior to launch and providing commercial input into development programs.
• Partnering with (R&D, Operations, Corporate Affairs, Finance, et al) and regional/local teams to develop relevant launch strategy. Additionally, working with regional colleagues to plan the market shaping activities 12-18 months prior to launch
• You are responsible for development and evolving the commercial strategy (positioning, messaging, claims, patient/HCP segmentation...etc.). in partnership with Regional Commercial leads to ensure local execution of strategy.
• You are responsible for the development, communication and evolution of long-range global forecasts for your portfolio (LTP)
• As the pipeline evolves, this role will also be instrumental in partnering with R&D, BD and other enterprise functions to support Business Cases for pipeline assets to be assessed by the Leadership team

Location: Barcelona - Spain (3 days working from the office and 2 days working from home)